MedPath

PRactice of VENTilation in Critically Ill PEDiatric Patients

Recruiting
Conditions
Critical Illness
Respiratory Failure
Registration Number
NCT06220825
Lead Sponsor
University Medical Center Groningen
Brief Summary

The goal of this worldwide observational study is to investigate ventilation practice in critically ill pediatric patients. The main questions it aims to answer are:

1. What is the global current practice of ventilatory support in critically ill pediatric patients?

2. Which potentially modifiable factors related to ventilation are associated with outcome? Participating pediatric intensive care units will gather detailed information about ventilation practice and outcome, such as duration of ventilatory support, length of ICU stay and ICU mortality.

Detailed Description

Rationale:

Studies on ventilatory support in critically ill pediatric patients remain scarce and much of the current clinical practice is based upon experience and data originating from critically ill adult patients.

Objectives:

1. To describe the worldwide practice of ventilatory support in critically ill pediatric patients; and

2. To identify potentially modifiable ventilation parameters that have independent associations with outcome.

Hypothesis:

1. Practice of ventilatory support in critically ill pediatric patients varies substantially worldwide; and

2. Potentially modifiable factors related to ventilation have independent associations with outcome in critically ill pediatric patients.

Study design:

International, multicenter, observational cohort study in critically ill pediatric patients. Each year, data will be collected in two predefined 4-week periods, one in the winter season and one in the summer season. A third 4-week period will be in case of epi- or pandemics. The study is designed to run for 10 years; within these 10 years, there will be subprojects during pre-defined periods. Centers have the option to opt out during certain time periods to make the study manageable for every participating country/center.

Study population:

Critically ill pediatric patients (aged 0-18) admitted to the pediatric intensive care unit (PICU) and necessitating ventilatory support \> 12 hours. Premature infants will be excluded. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Because of the observational design of the study using routinely collected data, there is no additional burden for the patient. Collection of data from ICU charts or electronic medical records systems is of no risk to the patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • Expected use of (non-)invasive respiratory support for at least 12 hrs
Exclusion Criteria
  • premature infants (i.e., postconceptional age corrected for gestational age < 40 weeks)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak inspiratory pressureFirst four days of (non-)invasive respiratory support

Peak inspiratory pressure

Plateau pressureFirst four days of (non-)invasive respiratory support

Pateau pressure

Driving pressureFirst four days of (non-)invasive respiratory support

Driving pressure

Mechanical powerFirst four days of (non-)invasive respiratory support

Mechanical power

Positive end-expiratory pressureFirst four days of (non-)invasive respiratory support

Positive end-expiratory pressure

Tidal volumeFirst four days of (non-)invasive respiratory support

Tidal volume

Secondary Outcome Measures
NameTimeMethod
Duration of respiratory support (in days)Up to 28 days following initiation of (non-)invasive respiratory support

Duration of respiratory support (in days)

ICU mortalityUp to 28 days following initiation of (non-)invasive respiratory support

ICU mortality

Ventilator-free days at day 28Up to 28 days following initiation of (non-)invasive respiratory support

Ventilator-free days at day 28

Length of ICU stay (in days)PICU admission

Length of ICU stay (in days)

PARDS prevalenceFirst four days of (non-)invasive respiratory support

Prevalence of PARDS per PALICC-2 definition

Trial Locations

Locations (1)

UMC Groningen

🇳🇱

Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath